Biodiversity-based innovation in the European Union
Key elements and practical implications of EU regulation 511/2014 - The EU Regulation implements the Nagoya Protocol. Its focus is on ensuring that companies and other organisations conducting R&D in the European Union monitor and comply with ABS rules in the country where the plant or other biological material or its derived substances come from.
of July 2016
When does the EU regulation on ABS apply?
The EU regulation on ABS applies to companies involved in the "utilisation of genetic resources". This term is defined as: conducting R&D on the genetic and/or biochemical composition of genetic resources. In 2016, the European Commission is set to provide guidance on the activities that fall within and outside the "utilisation of genetic resources". For now, there are no specific parameters. However, some R&D activities in food, cosmetics and natural pharmaceuticals are more likely to fall within this definition.This note
and illustrates the scope and obligations of the EU regulation.
Tags: Biodiversity policy | Health Care and pharmaceuticals
Other articles you might be interested in:
Voluntary Sustainability Standards and Biodiversity
Understanding the potential of agricultural standards for biodiversity protection - This policy brief provides a summary of the findings of joint research conducted by International Institute for Sustainable Development in collaboration with the Convention for Biological Diversity Secretariat analyzing the potential contribution of voluntary sustainability standards to support biodiversity protection.
Mexico launches biodiversity and business alliance
The Mexican Alliance for Biodiversity and Business, with the aim of promoting
the protection, conservation and restoration of biodiversity and ecosystems, was launched 17 October 2016 in Mexico City.
Defra report: Lessons learned from biodiversity offsetting markets
This study (Duke and ten Kate 2014, published in 2016) was commissioned by Defra to assist with the development of policy on biodiversity offsetting, in particular to support more detailed economic appraisal of the policy options identified in the 2013 Green Paper on Biodiversity Offsetting in England.